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Cardioventilator responses were studied in anaesthetized rats after injections of TRH into either the lateral (i.c.v. 
lat) or the fourth (i.c.v. IV) cerebral ventricles. TRH induced a morerapid hypertensive effect i.c.v. IV than i.c.v. lat. 
Blocking of the cerebral aqueduct abolished the hypertensive and tachypnoeic effects of TRH i.c.v. lat but not those of 
TRH i.c.v. IV. It is concluded that TRH increased blood pressure and ventilation rate via brain stem structures close 
to the fourtli ventricle. 
TRH Cardiovascular Ventilation Brain stem 
1. Introduction 
Thyrotropin releasing hormone (TRH) exerts a 
variety of effects in addition to i ts endocrine ac-
tion. Intracerebroventricular (i.c.v.) injections of 
TRH increase arterial pressure and heart rate in 
various species (Beale et al., 1977; Koivusalo et al., 
1979; Eriksson and Gordin, 1981). A hypertensive 
effect of TRH is also seen in humans receiving the 
compound intravenously for diagnostic purposes 
(Borowski et al., 1984). Moreover, TRH i.c.v. 
stimulates the ventilation rate (Koivusalo et al., 
1979; Hedner et al., 1983). Phylogenetic studies 
show that TRH is unable to stimulate thyroid 
function in certain amphibia and fish in spite of 
being abundantly present in the central nervous 
system. The finding that most of the TRH in the 
brain is found extrahypothalamically, that its 
binding sites are widely distributed in the CNS 
and that it is present in nerve terminals suggests 
that it would act as a neurotransmitter or neuro-
modulator (for review see Jackson, 1982). 
Cardiovascular or ventilator responses have 
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been elicited by local injections at various sites of 
the brain (e.g. Myers et al., 1977; Feuersteinet al., 
1983). However, the central sites involved in the 
cardioventilator effects of TRH are not known 
precisely. Both endogenaus TRH and its binding 
sites have been found in the region of the fourth 
ventricle (Eskay et al., 1983; Manaker et al., 1985). 
Accordingly, the present study was designed to 
find out to what extent the brain stem is involved 
in the cardioventilator effects of TRH. 
2. Materials and methods 
Male Wistar rats (240-300 g) were anaesthetized 
with urethane (1.5 gjkg i.p.). Ventilation rate (VR) 
and tidal volume (TV) were recorded by means of 
a hot wire flowmeter from the expiration of the 
spontaneously breathing rats. Mean arterial pres-
sure (MAP) and heart rate (HR) were recorded 
from the femoral artery. TRH or solvent was 
injected stereotaxically into the fourth (i.c.v. IV) or 
into the lateral (i.c.v. lat) cerebral ventricle in a 
volume of 10 JLl within 10-15 s. In some experi-
ments the cerebral aqueduct was blocked by verti-
cal insertion of a glass plate (0.1 mm thick and 3 
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mm wide) at 7 nun caudally from the bregma, 
corresponding to the midcollicular Ievel of the 
mesencephalon. The injection site was verified by 
staining with methylene blue. All the brains were 
examined histologically (HE staining) for determi-
nation of the exact Ievel of the aqueduct block. 
TRH (Sigma Chemical Co.) was dissolved in 
saline. In a pilot study a dose-dependent hyperten-
sive, tachycardic and tachypnoeic response was 
observed at i.c.v. lat doses of 0.3-300 nmoljrat. A 
submaximal dose of 100 nmoljrat of TRH was 
used in the present study. 
U nless stated otherwise, the results represent 
the maximal effects obtained within 15 min after 
each drug or treatment. Means ± S.E. are shown. 
Student's t-test for independent or dependent vari-
ables was used for statistical analysis. 
3. Results 
3.1. Time course of the effects of TRH 
TRH 100 nmoljrat i.c.v. IV or i.c.v. lat 
increased MAP and HR significantly and the max-
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Fig. 1. Effects of TRH 100 nmoljrat given into the lateral 
(i.c.v. lat, open symbols, n ... 7) or the fourth cerebral ventricle 
(i.c.v. IV, filled symbols, n = 6). Percentage changes in mean 
arterial pressure (MAP) are denoted as circles and those in 
heart rate (HR) as triangles. Statistical significance of the 
difference between i.c.v. IV and i.c.v. lat is indicated as follows: 
• P < 0.05, .. P < 0.01. Initial values in MAP (mm Hg) and 
HR (beats/min) respectively were: i.c.v. lat 103 ± 7, 427 ± 9; 
i.c.v. IV 95 ± 7, 417 ± 12. 
imal effects were similar (fig. 1). However, TRH 
i.c.v. IV increased MAP by 27% within 3 min 
while 7 min elapsed till the corresponding effect 
was reached after i.c.v. lat. The difference in the 
response times was significant (P < 0.01). HR 
showed a 5% increase after TRH i.c.v. IV after 10 
min while the same effect appeared within 3 min 
after TRH i.c.v.lat (P < 0.01). 
The TRH-induced increase in VR was 39 ± 12% 
(P < 0.05, n = 6) after i.c.v. IV and 27 ± 4% (P < 
0.01, n = 7) after i.c.v. lat. There were no signifi-
cant differences between the groups in the changes 
in VR recorded during the 15 min observation 
time. TRH i.c.v. IV increased TV by 80 ± 17% 
(P < 0.05, n = 6) while only a negligible effect was 
seen (6 ± 4%, n = 7) after TRH i.c.v. lat. The 
differences between groups were significant at 5-15 
min (P < 0.05-0.01 ). 
3.2. Effect of b/ockade of the cerebra/ aqueduct on 
the responses to TRH 
Blocking of the aqueduct did not cause signifi-
cant changes in MAP or VR (3 ± 6 mm Hg and 
-8 ± 6 breathsjmin respectively). However, HR 
and TV were set on a significantly higher Ievel for 
the entire duration of the experiment. The increase 
in HR was 43 ± 11 beatsjmin (P < 0.001) and that 
in TV 27 ± 7% (P < 0.05). 
In non-blocked rats TRH i.c.v. lat increased 
MAP significantly (fig. 2a) while only a negligible 
effect was seen in the presence of the block. How-
ever, in the presence of the block, TRH i.c.v. IV 
still exerted a strong hypertensive effect. In non-
blocked rats TRH i.c.v. lat induced a tachycardiac 
response while the heart rate increases after TRH 
i.c.v. lat or i.c.v. IV were not significant in pres-
ence of the block. 
In non-blocked rats TRH i.c.v. lat significantly 
increased VR while this effect was completely 
abolished after blocking of the aqueduct (fig. 2b). 
However, in the presence oftheblock TRH i.c.v. 
IV still induced a clear tachypnoeic response. In 
the absence oftheblock TRH i.c.v. lat caused only 
negligible effects on TV. In the presence of the 
block neither TRH i.c.v. lat nor TRH i.c.v. IV 
exerted any significant effects on TV. 
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Fig. 2. (a) Maximal effects of TRH 100 nmoljrat given either 
into the lateral (LA T) or the fourth cerebral ventricle (IV). 
Filled bars: TRH treatment (n = 6); open bars: solvent (n = 6). 
The group of bars on the left shows the changes in mean 
arterial pressure (MAP) and that on the right shows the changes 
in heart rate (HR). The line under the rightmost four bars in 
each group (--) represents effects in the presence of the 
block of the cerebral aqueduct. Statistical significance vs. solvent 
is denoted as follows: * P < 0.05, *** P < 0.001. Initial values 
in MAP (mm Hg) and HR (beatsjmin) respectively were: LAT 
112±9, 452±5; LAT with block 122±18, 510±17; IV with 
block 116 ± 14, 525 ± 20. These values did not differ statistically 
from those for the group treated with solvent. (b) Maximal 
effects of TRH 100 nmoljrat given into the lateral (LA T) or 
the fourth cerebral ventricle (IV). Filled bars: TRH treatment 
(n = 6); open bars: solvent (n = 6). The group of bars on the 
left shows the changes in ventilation rate (VR) and that on the 
right shows the changes in ventilation tidal volume (TV). The 
line under the rightmost four bars in each group (L.....--J) 
represents effects in the presence of the block of the cerebral 
aqueduct. Statistical significance vs. solvent is denoted as fol-
lows: *** P < 0.001. Initial values in VR (breathsjmin) were: 
LA T 93 ± 5, LA T with block 130 ± 6, IV with block 98 ± 3. 
These values did not differ statistically from those for the 
group treated with solvent. The percentage changes in TV were 
calculated from arbitrary units. 
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4. Discussion 
TRH given in the fourth cerebral ventricle in-
duced a more rapid increase in blood pressure 
than TRH given in the lateral ventricle. Moreover, 
TRH still exerted a strong hypertensive effect in 
the fourth ventricle when its access to the third 
and lateral ventricles was bindered by the aque-
duct block. These findings indicate that at least a 
part of the hypertensive effect of TRH was medi-
ated via brain stem structures close to the fourth 
ventricle. It is consistent with the present n!sults 
that an almost instantpresser response (20 s) was 
seen after intracisternal·injection of TRH in rab-
bits (Beale et al., 1977). The fact that the aqueduct 
block abolished the hypertensive effect of TRH in 
the lateral ventricle does not exclude other sites of 
action e.g. the hypothalamus or the preoptic area 
as suggested by others (Feuerstein et al., 1983). lt 
is possible that the partial transection of the 
mesencephalon damaged those descending path-
ways necessary for the expression of the hyperten-
sive effect of TRH in the diencephalic sites. 
TRH induced a more rapid tachycardiac re-
sponse when given in the lateral than when given 
in the fourth ventricle, suggesting a site of action 
rostral to the fourth ventricle. This notion also 
conforms with the finding that in blocked rats 
TRH did not inöuce any significant tachycardia 
when given in the fourth ventricle. However, no 
conclusive evidence could be obtained because of 
the failure of TRH to induce significant tachy-
cardia from the lateral ventricle after blocking of 
the aqueduct. A possible explanation for the Iack 
of effect could be the partial transection and the 
initially higher heart rate level due to the block. In 
accordance with a previous report (Sin!n and 
Paakkari, 1984) the results suggest that the hy-
pertensive and tachycardiac effects of TRH were 
not mediated via identical mechanisms. 
The region of the fourth ventricle was involved 
in the tachypnoeic effect of TRH since a strong 
increase in ventilation rate was induced by TRH 
given in the fourth ventricle in spite of the aque-
duct block. Also Hedner et al. (1983) found that 
the Stimulation of the ventilation rate by TRH was 
strongest when the compound was administered 
into the fourth ventricle. 
In accordance with earlier reports (e.g. 
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Koivusalo et al., 1979; Hedner et al., 1983) no 
increase in ventilation tidal volume was seen after 
the injection of TRH into the lateral ventricle. 
However, in the present study a clear increase in 
tidal volume was observed when the compound 
was injected into the fourth ventricle in non-
blocked animals but not in those with the block. 
The absence of the effect in the latter group may 
have been due to the increased basal tidal volume 
caused by the block. An alternative explanation 
could be that the block in the mesencephalic Ievel 
ablated the area sensitive to this particular effect 
of TRH. Myers et al. (1977) reported an increase 
in ventilation rate after local mesencephalic injec-
tions of TRH. However, no data on the possible 
changes in tidal volume were presented. 
The present findings suggest that TRH may be 
involved in cardioventilator regulation in the brain 
stem regions close to the fourth cerebral ventricle. 
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